Tvardi Therapeutics Inc (TVRD)
SG&A Expense Growth
-66.89%
Fiscal year · Period ending:
TVRD SG&A Expense Growth
Latest reported-66.89%period ending
Latest reported-66.89%period ending
TVRD FY SG&A Growth (YoY) (0.00% → -66.89%)
Latest values, visible window
High-resolution chart · PNG
TVRD sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -66.8903% | |
| -4.5607% | |
| -8.2313% | |
| 7.6843% | |
| 33.596% | |
| 0% |